Franciscan Missionaries of Our Lady Health System
Questions or Suggestions
Drug Information Questions
Search by name
Search by class
Browse alphabetically
Select...
NUM
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
High Alert
Black Box Warning
Hazardous Drugs
Do Not Crush
Therapeutic Interchange
Do Not Tube-LALK
Do Not Tube-LACH
Restricted
CMS Self-Administered Drug Exclusion List
Look Alike Sound Alike Drugs
Webpage Links
Add Formweb to your mobile device
Android
iOS
Home
QuickStart
Admin
News
Boards
*COVID-19 Pharmacy Resources
Franciscan Missionaries of Our Lady Health System
Questions or Suggestions
Drug Information Questions
Search by name
Additional search options
Search by class
Browse alphabetically
Select...
NUM
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
High Alert
Black Box Warning
Hazardous Drugs
Do Not Crush
Therapeutic Interchange
Do Not Tube-LALK
Do Not Tube-LACH
Restricted
CMS Self-Administered Drug Exclusion List
Look Alike Sound Alike Drugs
Webpage Links
Search results for:
tranexamic acid
tranexamic acid
Brand names:
Cyklokapron
Form
Strength
ANAN
ASMP
LACH
LALK
LOHH
LOLR
LOWC
SDSD
SESE
SFSF
Formulary Status
SOLUTION, INTRAVENOUS
10 mg/mL-NaCl 0.7%; 100 mg/mL
TABLET, ORAL
650 mg
VIEW MORE
Hemostatics
CLASS
202816
Comments:
Screen for contraindications to TXA use prior to administration
hypersensitivity to TXA
Active thromboembolic disease
History of thrombosis or thromboembolism
Intrinsic risk of thrombosis
Last updated:
Nov. 30, 2021
UpToDate
FDA Package Inserts
Acadiana Market Specific P&T Updates
Jackson Market Specific P&T Updates
Screen for contraindications to TXA use prior to administration